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ORIGINAL RESEARCH Open Access
Assessing radiotracer kinetics in the Langendorff
perfused heart
Erika Mariotti1*, Mattia Veronese2, Joel T Dunn1, Rodolfo A Medina1, Philip J Blower1, Richard Southworth1
and Thomas R Eykyn1,3
Abstract
Background: The Langendorff perfused heart is a physiologically relevant and controllable model with potential for
assessing the pharmacokinetics of new radiotracers under a range of pathophysiological conditions.. We assess the
feasibility of extending the methods validated for in vivo PET data analysis to the characterisation of PET tracer
kinetics applied to Langendorff perfused hearts.
Methods: Monte Carlo simulations were used to study the accuracy and reproducibility of linear and non-linear
spectral analysis (SA/NLSA), the Patlak graphical method and normalised tissue activity (NA). The methods were
used to analyse time-activity curves of two widely used PET tracers, [18 F]-FDG and [18 F]-FMISO, acquired ex vivo
from Langendorff perfused rat hearts under normoxic and hypoxic conditions.
Results: Monte Carlo simulations showed NLSA to be superior to SA in identifying and quantifying the presence of
irreversible trapping component (αo), for low values of αo. The performance of NLSA and SA for high values of
trapping was comparable. NLSA was also more precise than SA in determining the absence of trapping over the
range of simulated kinetics and SNR. Simulations also suggest that the semi-quantitative method NA is adequate
for the evaluation of trapping, and it was found to be more accurate than Patlak. The values of α0 estimated with
NLSA from the time series of both [18 F]-FDG and [18 F]-FMISO increased significantly from normoxia to hypoxia in
agreement with previous studies. The values of trapping derived using SA increased but not significantly, reflecting
the larger error associate with this method. Patlak estimated from the experimental datasets increased from normoxia
to hypoxia but was not significant. NA estimated from the [18 F]-FDG data increased from normoxia to hypoxia, but was
not significant, whilst NA calculated for [18 F]-FMISO time-activity curves increased significantly.
Conclusions: Monte Carlo simulations suggested that spectral-based quantitative analysis methods are adequate for
the kinetic characterisation of time-activity curves acquired ex vivo from perfused hearts. The uptake rate Patlak and the
index NA also represent a good alternative to the SA and NLSA algorithms when the aim of the kinetic analysis is to
measure changes in the amount of tracer trapped in the irreversible compartment in response to external stimuli. For
low levels of trapping, NLSA and NA were subject to lower errors than SA and Patlak, respectively.
Keywords: PET; Spectral analysis; Kinetic modelling; [18 F]-FDG; [18 F]-FMISO; Perfused heart
Background
The isolated perfused heart is commonly used for the
early evaluation of pharmaceuticals as well as being able
to assess novel radiotracer pharmacokinetics [1-3]. It is a
dynamic, biologically relevant model, with an intact vas-
culature, which provides insight into tracer uptake and
retention in a metabolically active beating heart, without
the potential complications of systemic metabolism and
recirculation. It is versatile in terms of allowing direct
drug and tracer administration; control of perfusion, work-
load and energy substrate supply; simple induction of hyp-
oxia or ischemia; and the capacity to monitor the effects of
such interventions upon cardiac contractile function and
biochemistry [4-9].
Ex vivo time-activity curves of Positron Emission
Tomography (PET) tracers from the isolated heart can be
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acquired through single or multiple NaI γ-detectors with
no spatial information but very high temporal resolution
[2,10]. Delivery input functions (Cin(t)) can be measured in
a Langendorff perfused heart with a γ-detector coupled
to the inflow line, while time-activity curves in the heart
(Ctiss(t)) can be acquired using a single γ-detector inter-
rogating the entire isolated perfused heart (see Figure 1).
As tracer uptake is heterogeneous across the myocardium
(from endocardium to epicardium, for example [11]), time-
activity curves from perfused hearts likely represent a more
heterogeneous range of kinetics than spatially resolved im-
aging data. Ex vivo time-activity curves further differ from
those acquired in vivo in terms of signal-to-noise ratio
(SNR) and lack of recirculation leading to an input func-
tion that decays rapidly to zero. In order to relate the
measured activity to the underlying physiological or
biochemical processes, the application of mathematical
models to describe tracer kinetics is necessary.
A number of quantitative and semi-quantitative ana-
lysis methods are available for the evaluation of PET
tracer kinetics in vivo, but to date, relatively few studies
have investigated their validity for characterisation of
PET tracers ex vivo, where there is the potential to gain
biochemical insight into the nature of radiotracer trap-
ping mechanisms or disease processes under more read-
ily controlled experimental conditions. Previous studies
have fitted time-activity curves from isolated hearts with
exponential functions characterised by an arbitrary num-
ber of rates and quantified the tracer retention by aver-
aging the activity measured in a chosen time interval at
the end of the acquisition window [10]. This approach
assumes the presence of an irreversible trapping compo-
nent and the number of kinetic rates characteristic of a
particular tracer a priori. The approach also rarely in-
cludes consideration of the delivery input function as a
means of accurately quantifying tracer tissue kinetics.
In this study, we explore the possibility of extending
the approaches used for the analysis of in vivo PET data
to the kinetic analysis of time-activity curves acquired
from Langendorff perfused rat hearts. We assess the accur-
acy and reproducibility of quantitative spectral analysis
(SA) [12] and non-linear spectral analysis (NLSA) methods
[13], as well as of the graphical method Patlak [14] and
the semi-quantitative index normalised activity (NA) in
both simulated and experimental ex vivo PET datasets.
These methods were chosen because they can be applied
to homogenous as well as heterogeneous systems with-
out any a priori hypothesis on the number of com-
partments necessary to describe the data. Monte Carlo
simulations were used to compare the performance of SA
and NLSA in (1) identifying the presence of irreversible
trapping, (2) deriving the number of kinetic components
and (3) quantifying the irreversible trapping component
from ex vivo time-activity curves. SA and NLSA were used
to analyse experimental ex vivo time-activity curves ac-
quired from isolated perfused rat hearts after the injection
of two widely used PET tracers, [18 F]-FDG and [18 F]-
FMISO, and compared with the uptake rate Patlak and
the index NA in normoxic conditions and in response to
hypoxia.
Methods
Spectral analysis
In SA, the tissue activity at time t, Ctiss(t), is modelled as a
convolution of the delivery input function, Cin(t), with the
sum of M + 1 distinct exponential terms as in Equation 1.
Ctiss tð Þ ¼
XM
j¼0
Cin tð Þ⊗αje−βjt ð1Þ
αj and βj are assumed to be real non-negative values.
The upper limit, M, represents the maximum number of
Figure 1 Experimental set-up. In each experiment, a bolus of [18 F]-FDG or [18 F]-FMISO was injected through the injection port, and its passage
through the perfusion line was recorded using two NaI γ-detectors which are able to measure the input (detector 1) and the tissue (detector 2)
time-activity curves.
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terms to be included in the model. The values of the
rates βj are predetermined and fixed in order to cover a
range of all possible kinetic components measurable
from the data. The values of the amplitudes αj are esti-
mated from the input and tissue time-activity curves by
non-negative least square algorithm, and normally, only
a few components with αj > 0 are detected.
Spectral analysis was implemented as previously re-
ported [15], with Ctiss(t) referring to the activity of the
tracer measured in the whole heart and Cin(t) associated
to the measured delivery input function. The grid of
values of the rates βj (β1 < β2 <… < βM) (Equation 1) was
defined as a logarithmic distribution with lower limit
β1 = 1/(3Tend), where Tend was the end time of the experi-
ment, and upper limit βM = 3/Tin in agreement with pre-
vious studies [16]. Tin was the duration of the first time
frame of the experiment. The number of pointsM between
β1 and βM was chosen equal to 100. A component for β = 0
was included in the model, corresponding to a fully
trapped component. The M + 1 unknown values of αj were
estimated through a non-negative least square estimator.
Weights were inversely proportional to the variance of
decay-corrected measured activity. The SA algorithm was
implemented in Matlab (the MathWorks, Natik, USA).
Non-linear spectral analysis
For the implementation of NLSA, it is not necessary to
specify a grid of values of βj. The M + 1 unknown values
of βj and αj were estimated through non-linear fitting
with the initial conditions chosen within a physiological
range (and in agreement with [13]) maintained constant
for all datasets analysed. The number of exponentials
necessary to give a good fit of the data M (Equation 1)
was fixed between 1 and up to a maximum of 4, in agree-
ment with previous studies [13]. The Akaike information
criterion (AIC) [17] was used to choose the model that best
fit the data. Weights were inversely proportional to the
variance of decay-corrected measured activity. The NLSA
algorithm was implemented in Matlab (the MathWorks,
Natik, USA).
Graphical method: Patlak plot
Due to the demonstrated irreversible tissue retention of
the tested tracers [13,18], the Patlak plot (given by the
expression below) was chosen among the available graph-
ical methods [14]:
Ctiss tð Þ
Cin tð Þ ¼ K
Z t
0
Cin τð Þdτ
Cin tð Þ þ V ð2Þ
where K represents the net uptake rate of the tracer and V
the distribution of the tracer in the compartment that
is in rapid equilibrium with the plasma. The unknown
constants K and V were obtained by linear regression
from a graph of Ctiss(t)/Cin(t) against
Z t
0
Cin τð Þdτ=Cin tð Þ
computed for t > 7.5 min. Because of the large number
of data points (five samples per second), both quantities
were interpolated on a 6-s sub-sampled grid. K was the ul-
timate parameter of interest considered, while V was ex-
cluded from the tracer kinetic analysis.
Normalised activity
We defined the NA as a surrogate of the semi-quantitative
index standard uptake value (SUV) used for the character-
isation of tracer trapping in vivo. SUV is given by the ratio
of the tissue radioactivity and the injected radioactivity di-
vided by the body weight [19]. In ex vivo experiments, the
input function is delivered as an impulse with no recircula-
tion, and therefore, the plasma radioactivity rapidly decays
to zero. Additionally, due to the experimental set-up,
the measured activity is not directly proportional to the
radioactivity concentration. For these reasons, the semi-
quantitative index SUV could not be computed in this
study as it is defined for in vivo experiments. We define a
new index, NA, in which the maximum measured activity
in the target tissue substituted the normalised injected
dose of the tracer normally used in SUV. NA was calcu-
lated as a ratio of the mean tissue activity (Ctiss(t)) mea-
sured in counts per second (CPS) over a small interval at
the end of the experiment [end − 0.075 min, tend] and the
maximum value of Ctiss(t) (CPS).
NA ¼ mean Ctiss tend−0:075min; tendð Þh i
max Ctiss tð Þð Þ ð3Þ
Simulation studies
Datasets were simulated, reproducing the characteristics
of ex vivo time-activity curves from isolated hearts in
normoxia and at different levels of hypoxia. Bi- and tri-
exponential ex vivo time-activity curves with known kin-
etics were simulated using Equation 1. The values of βj
were fixed (for tri-exponentials, β1 = 0.5 min
−1, β2 =
5 min−1 and β3 = 15 min
−1; and for bi-exponentials, β1 =
0.5 min−1and β2 = 15 min
−1), whereas αj were randomly
generated within a chosen interval (for tri-exponentials,
0.011 min−1 < α1 < 0.11 min
−1, 0.12 min−1 < α2 < 0.2 min
−1,
and 5 min−1 < α3 < 8 min
−1; and for bi-exponentials,
0.011 min−1 < α1 < 0.11 min
−1 and 5 min−1 < α2 < 8 min
−1).
Bi- and tri-exponential curves were simulated with and
without a trapping component α0 (for β0 = 0). Four differ-
ent values of irreversible trapping were simulated (α0,1 =
0.006 min−1, α0,2 = 0.06 min
−1, α0,3 = 0.2 min
−1 and α0,4 =
0.6 min−1) (see Figure 2). The values used in the simula-
tions were chosen within a physiological range and in
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agreement with previous studies [13]. To obviate further
sources of variability between one dataset and another,
the same Cin(t) was taken from an experimental dataset,
representative of these experiments, and used for all sim-
ulations. Each dataset was simulated for a low and a high
SNR (SNR = 60 and SNR = 120), consistent with the ex-
perimental data, and N = 100 and a time resolution Δt =
0.0033 min were chosen. SNR was computed as the ratio
of the maximum value of the time-activity curve and the
standard deviation of the signal in the last minute of each
experiment [20].
The percent bias (%BIAS) of quantitative and semi-
quantitative indices (α0, Patlak and NA) was calculated
as a performance index (Equation 4).
%BIASp ¼ 100 
Xk
j¼1
pj−pTRUE
 
pTRUE
ð4Þ
Figure 2 Simulated datasets. (A) Representative input function used in the simulations. (B) Representative simulated heart time-activity curves
for different values of irreversible trapping components (α0). The dynamics simulated were chosen to mimic the tissue time-activity curves of
hypoxia-sensitive tracers characterised by an increase in tracer uptake when the perfused heart is made hypoxic compared to that measure
in normoxia.
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where pj and pTRUE are the estimated and true value of
the indices p.
Experimental protocol
All procedures were performed in accordance with the
United Kingdom Home Office Guide on the Operation
of the Animals (Scientific Procedures) Act 1986 and
KCL's Ethical Review Process Committee.
[18 F]-FDG was provided by the clinical PET Centre,
St. Thomas' Hospital, whereas [18 F]-FMISO was pre-
pared following a previously reported method [21].
Mature male Wistar rats (250 to 300 g) were fed ad
libitum with regular animal feed. Hearts (n = 4 for [18 F]-
FDG and n = 3 for [18 F]-FMISO) were harvested under
terminal anaesthesia (sodium pentobarbitone (100 mg/kg)
intraperitoneal injection with heparin (200 IU)) and
plunged into ice-cold Krebs Henseleit buffer (KHB), with
the following composition: NaCl 118 mM, NaHCO3
25 mM, MgSO4 1.2 mM, KCl 5.9 mM, Na2EDTA 0.6 mM,
glucose 11.1 mM and CaCl2 2.5 mM, pH 7.4. Hearts were
cannulated via the aorta and retrogradely perfused at con-
stant flow (14 ml/min) with KHB at 37°C. Cardiac con-
tractile function was monitored with a water-filled balloon
inserted into the left ventricular lumen inflated to record
an end diastolic pressure of 6 to 8 mmHg, which was con-
nected to a pressure transducer and recording apparatus.
Perfusion pressure was measured by a further pressure
transducer inserted into the arterial line. A bolus of each
radiotracer (1 MBq in 100 μl KHB) was administered via
an in-line injection port, and its transit through the perfu-
sion apparatus was monitored by NaI detectors (1) in the
arterial line above the heart cannula and (2) directly oppos-
ite the heart (to quantify the tracer accumulation in the
heart) connected to a GinaSTAR TM ITLC unit (see
Figure 1). All datasets were acquired with a time reso-
lution Δt = 0.0033 min.
After a stabilisation period, where KHB perfusate was
gassed with 95% O2-5% CO2, the first bolus of either
[18 F]-FDG or [18 F]-FMISO was injected into the per-
fusion line, and their passage through the system under
‘normoxic’ conditions was recorded. After 5 min, hypoxia
was induced by switching to a second reservoir (KHB
gassed with 95% N2-5% CO2). Further boli of each tracer
were injected into the system after 5 min and 15 min
of hypoxic buffer perfusion, respectively, and the kinetics
of cardiac retention monitored. A scheme of the experi-
mental protocol used to acquire [18 F]-FDG and [18 F]-
FMISO plasma and tissue time-activity curves is shown in
Figure 3A, whereas a representative experimental dataset is
shown in Figure 3B.
Data correction
All datasets were corrected for radioactive decay. Addition-
ally, to adjust the experimental data for residual activity
due to prior injections in the same heart, a model pre-
diction correction was used. The normoxic input/tissue
time-activity curve was fitted with the algorithm assessed
(SA or NLSA), and the result was extrapolated in the
time interval relative to the second injection. The contri-
bution of the activity from the first injection to the sec-
ond was therefore calculated and subtracted. After the
background correction, the curve relative to the second
injection was fitted and its contribution subtracted to the
third injection.
Statistical analysis
Statistical analysis was performed using GraphPad Prism®
(GraphPad Software Inc, USA). All values are expressed as
the mean ± SD. Data were analysed using a one-way
ANOVA with Dunnett's test to compare each group of
datasets acquired in hypoxia with the corresponding con-
trol group measured in normoxia [22].
Results
Simulations
The results from the Monte Carlo simulations highlighted
differences in performance of the two assessed spectral-
based algorithms, the uptake rate Patlak and the semi-
quantitative index NA.
Results from Monte Carlo simulations showed that
NLSA is more accurate in identifying the absence of irre-
versible trapping (α0 = 0 min
−1) for the dynamics and SNRs
considered (see Table 1). For the lowest value of the trap-
ping simulated (α0 = 0.006 min
−1) with tri-exponential kin-
etics, a similar degree of accuracy was found for SA and
NLSA, whereas for bi-exponential kinetics, SA was found
to be superior. For higher values of trapping, the accuracy
in estimating the presence of the trapping of the two algo-
rithms was equal to 100% (see Table 1).
The mean and the standard deviation of the %BIASα0
(Equation 4) reported with NLSA and SA for both bi- and
tri-exponential curves and high and low SNRs are shown
in Figure 4. For tri-exponential kinetics (see Figure 4A,C),
NLSA displayed a lower bias than SA for the quanti-
fication of small α0 values with a maximum mean ± SD
percentage bias equal to 38.30% ± 4.92% for NLSA com-
pared to 176.15% ± 114.65% for SA at α0,1 = 0.006 min
−1
and SNR = 60. For higher values of trapping (α0,3 =
0.2 min−1 and α0,4 = 0.6 min
−1), SA and NLSA were of
similar accuracy, with a minimum mean ± SD %BIASα0
equal to 0.17% ± 0.03% for SA, compared to 1.55% ±
0.34% for NLSA at α0,4 = 0.6 min
−1 and SNR = 120. The
same trend was found for bi-exponential curves (see
Figure 4B, D), where the maximum mean ± SD %BIASα0
were 16.41% ± 4.71% for NLSA and 228.39% ± 117.70% for
SA, at α0,1 = 0.006 min
−1 and SNR = 60. The minimum
mean ± SD %BIASα0 values for high trapping were similar
with those found for tri-exponential kinetics. The accuracy
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in quantification of α0 for both NLSA and SA algorithms
improved with increasing values of trapping and SNR.
Additionally, the mean ± SD percentage bias reported for
both algorithms was generally lower for bi-exponential
curves than those estimated for tri-exponential kinetics.
In Figure 5A,B, the mean and the standard deviation
of the %BIAS reported for Patlak and NA are presented
for simulated tri-exponential curves. In the absence of
noise, Patlak returns the exact value of α0, whereas NA
represents a surrogate of the trapping component which
is in a linear relationship. The accuracy in quantify-
ing the trapping component from the simulated data
using Patlak increased with the value of trapping and
SNR with a maximum mean ± SD percentage bias equal
to −1,662% ± 1,053.8% at SNR = 60 and −507% ± 230% at
SNR = 120 and a minimum mean ± SD percentage bias
equal to −20.2% ± 3% at SNR = 60 and −12.2% ± 2.5% at
SNR = 120. The maximum mean ± SD percentage bias
reported for NA is 5.3% ± 10% (a.u.) at SNR = 60 and
3.2% ± 10% (a.u.) at SNR = 120, while the minimum
mean ± SD percentage bias is equal to 0.8% ± 12.4% (a.u.)
at SNR = 60 and 0.6% ± 12.4% (a.u.) at SNR = 120. The
values reported for the %BIAS of both Patlak and NA esti-
mated from bi-exponential curves were not significantly
different from those calculated for tri-exponential curves
(data not reported).
Table 2 shows the performance of the NLSA and SA
algorithm in estimating the number of non-trapped com-
ponents from simulated bi- and tri-exponential curves. Re-
sults showed the percentage of datasets where the number
of components was under estimated (UE), over esti-
mated (OE) or correctly estimated (CE). For tri-exponential
Figure 3 Experimental protocol. (A) Schematic representation of the experimental protocol used to acquire [18 F]-FDG and [18 F]-FMISO ex vivo
time-activity curves from perfused rat hearts. After a stabilisation period, where the KHB perfusate was gassed with 95% O2-5% CO2, the first
bolus of either [18 F]-FDG or [18 F]-FMISO was injected into the perfusion line. After 5 min, hypoxia was induced by switching to a second reservoir
with KHB gassed with 95% N2-5% CO2. Further boli of each tracer were then injected into the system after 5 min and 15 min of hypoxic buffer
perfusion, respectively. (B) Representative [18 F]-FDG input and tissue time-activity curves acquired ex vivo using the protocol described in (A) (y-axis units
are counts per second).
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Table 1 Proportion of simulations that had α0 = 0 or α0 ≠ 0 identified by NLSA and SA
Simulated scenario NLSA performance SA performance
SNR = 60 SNR = 120 SNR = 60 SNR = 120
α0 = 0
(%)
α0 ≠ 0
(%)
Accuracy
(%)
α0 = 0
(%)
α0 ≠ 0
(%)
Accuracy
(%)
α0 = 0
(%)
α0 ≠ 0
(%)
Accuracy
(%)
α0 = 0
(%)
α0 ≠ 0
(%)
Accuracy
(%)
Tri-exponential
No trapping (α0 = 0) 100 - 100 100 - 100 21 79 21 14 86 14
Trapping 1 (α0 = 0.006) 10 90 90 6 94 94 6 94 94 10 90 90
Trapping 2 (α0 = 0.06) - 100 100 - 100 100 - 100 100 - 100 100
Trapping 3 (α0 = 0.2) - 100 100 - 100 100 - 100 100 - 100 100
Trapping 4 (α0 = 0.6) - 100 100 - 100 100 - 100 100 - 100 100
Bi-exponential
No trapping (α0 = 0) 100 - 100 100 - 100 14 86 14 2 98 2
Trapping 1 (α0 = 0.006) 23 77 77 13 87 87 4 96 96 - 100 100
Trapping 2 (α0 = 0.06) 6 94 94 2 98 98 - 100 100 - 100 100
Trapping 3 (α0 = 0.2) - 100 100 - 100 100 - 100 100 - 100 100
Trapping 4 (α0 = 0.6) - 100 100 - 100 100 - 100 100 - 100 100
α0 indicates the tracer trapping. Units are in min
−1.
Figure 4 Results for the estimation of α0 from the Monte Carlo simulations. Bias (percent) in calculated trapping (α0) of the NLSA and SA
algorithm applied to simulated (A, C) tri-exponential and (B, D) bi-exponential models. α0,i indicates the trapping of the tracer with the values
reported in Table 1. Units are in min−1.
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time-activity curves, the accuracy in determining the
number of components was better for NLSA when
α0 = 0 min
−1, whilst SA was better at all other values of
α0 simulated. For bi-exponential kinetics, the accuracy in
determining the number of components was significantly
better than for tri-exponential time-activity curves. NLSA
was more accurate when α0 = 0 min
−1, whereas SA was
more accurate than NLSA for all non-zero values of trap-
ping simulated.
Experimental datasets
Figure 3B shows representative time-activity curves ac-
quired from an isolated perfused rat heart using the ex-
perimental set-up and protocol presented in Figures 1
and 3A, respectively. Cardiac contractile function of
the perfused hearts was monitored throughout the ex-
periment. The left ventricular end diastolic pressure
(LVEDP) increased from 7 mmHg ± 2 mmHg in normoxia
to 29 mmHg ± 6 mmHg after 5-min hypoxia and further
to 79 mmHg± 8 mmHg after 15-min hypoxia. The left
ventricular developed pressure (LVDP) decreased from
142 mmHg ± 5 mmHg in normoxia to 48 mmHg ±
5 mmHg after 5-min hypoxia and further to 25 mmHg ±
4 mmHg after 15-min hypoxia.
Two time-activity curves were detected for each ex-
periment: one representative of the delivery input func-
tion and a second reflecting the tracer accumulation in
the heart. Both curves were corrected for the radioactive
decay and residual tracer content in the heart from pre-
vious injections. In Figure 6, a representative normoxic
dataset after decay and background correction (coloured
dots) is shown with overlaid fits (coloured lines). The
SNRs estimated for the [18 F]-FDG time-activity curves
were 165 ± 40 in normoxia, 129 ± 35 at 5-min hypoxia
and 103 ± 32 at 15-min hypoxia. The SNRs estimated for
the [18 F]-FMISO time-activity curves were 253 ± 117
in normoxia, 182 ± 20 at 5-min hypoxia and 151 ± 17 at
15-min hypoxia.
Figure 5 Results for Patlak and NA from the Monte Carlo simulations. Bias (percent) reported for (A) Patlak and (B) NA applied to simulated
tri-exponential time-activity curves.
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Results from the NLSA and SA quantification of [18 F]-
FDG datasets (n = 4) are shown in Table 3. The NLSA
algorithm always identified a trapping component α0
(with the exception of one dataset run 4, hypoxia 1),
whereas SA determined a null trapping component for
5 datasets out of 12. NLSA identified four kinetic compo-
nents different from α0, while SA identified between three
and five components.
Figure 7A shows the mean ± SD of the trapping quan-
tified with NLSA and SA. The value of α0 estimated with
Figure 6 Fitting of a representative [18 F]-FDG ex vivo dataset. (A) Experimental input function (blue dots) with overlaid fit (green).
(B, C) Experimental heart data (red dots) with overlaid NLSA (blue) and SA (black) fits.
Table 2 Proportion of simulations that had the number of components underestimated, overestimated or correctly
estimated by NLSA and SA
Simulated scenario NLSA performance SA performance
SNR = 60 SNR = 120 SNR = 60 SNR = 120
UE (%) OE (%) CE (%) UE (%) OE (%) CE (%) UE (%) OE (%) CE (%) UE (%) OE (%) CE (%)
Tri-exponential
No trapping (α0 = 0) 85 - 15 0 - 100 - 81a 19a - 100a 0a
Trapping 1 (α0 = 0.006) 100 - 0 46 - 54 18 - 82 - - 100
Trapping 2 (α0 = 0.06) 100 - 0 60 - 40 18 - 82 - - 100
Trapping 3 (α0 = 0.2) 100 - 0 95 - 5 46 - 54 - - 100
Trapping 4 (α0 = 0.6) 100 - 0 100 - 0 53 - 47 1 - 99
Bi-exponential
No trapping (α0 = 0) - - 100 - - 100 - 86a 14a - - 100a
Trapping 1 (α0 = 0.006) 1 - 99 - - 100 17 18 65 - - 100
Trapping 2 (α0 = 0.06) 1 - 99 - - 100 - - 100 - - 100
Trapping 3 (α0 = 0.2) 11 - 89 5 - 95 - - 100 - - 100
Trapping 4 (α0 = 0.6) 34 - 66 32 - 68 - - 100 - - 100
α0 indicates the tracer trapping. Units are in min
−1; UE, underestimated number of components; OE, overestimated number of components; CE, correctly
estimated. Results are shown only for the percentage of datasets where the presence of baseline was correctly estimated (Table 1). aAn accuracy in baseline
identification was <25%.
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NLSA significantly increased from 0.04 min−1 ± 0.02 min−1
in normoxia to 0.20 min−1 ± 0.11 min−1 at 15-min hypoxia
(p < 0.05). The mean ± SD of the trapped component esti-
mated with SA did not change significantly between nor-
moxia and hypoxia and was associated with a larger error.
The coefficient of variation (CVα0 (%)) associated with the
estimation of the trapping component was smaller for
NLSA than SA. The CVα0 (%) in normoxia was 3.4% ± 2%
for NLSA and 181.2% ± 308.9% for SA. At 15-min hypoxia,
it was 8.2% ± 7% and 36.3% ± 41.8% for NLSA and SA, re-
spectively. Figure 8A shows the mean ± SD of Patlak and
NA calculated for [18 F]-FDG. The value of Patlak in-
creased, but not significantly, from 0.06 min−1 ± 0.02 min−1
in normoxia to 0.19 min−1 ± 0.09 min−1 at 15-min hypoxia.
NA also increased from 0.03 ± 0.01 (a.u.) in normoxia to
0.04 ± 0.02 (a.u.) at 15-min hypoxia, but not significantly.
Table 4 shows the results from the NLSA and SA quanti-
fication for [18 F]-FMISO datasets (n = 3). The NLSA algo-
rithm always identified a trapping component α0, whereas
SA determined a null trapping component for one of the
dataset (run 2, normoxia). The number of kinetic com-
ponents different from α0 identified is four using NLSA
and between two and four with SA. Figure 7B shows the
mean ± SD of the trapping quantified with NLSA and
SA. The value of α0 estimated with NLSA significantly
increased from 0.005 min−1 ± 0.002 min−1 in normoxia to
0.03 min−1 ± 0.0002 min−1 at 15-min hypoxia (p < 0.05).
The mean ± SD of the trapping component derived through
SA also changed from 0.004 ± 0.00025 min−1 in normoxia
to 0.0148 ± 0.0023 min−1 at 15-min hypoxia, but not sig-
nificantly. As found for the [18 F]-FDG time-activity curves,
the CVα0 (%) reported for NLSA was much smaller than
that reported for SA. The CVα0 in normoxia was 4% ±
0.6% for NLSA and 16.1% ± 18.3% for SA. At 15-min hyp-
oxia, it was 1.3% ± 0.2% and 13.7% ± 7% for NLSA and SA,
respectively.
In Figure 8B, the mean ± SD of Patlak and NA calculated
for [18 F]-FMISO time-activity curves is reported. The
value of Patlak increased from 0.005 min−1 ± 0.001 min−1
in normoxia to 0.031 min−1 ± 0.01 min−1 at 15-min hyp-
oxia, but was not significant. NA increased significantly
from 0.007 ± 0.002 (a.u.) in normoxia to 0.02 ± 0.006 (a.u.)
at 15-min hypoxia (p < 0.05).
Discussion
The results from the Monte Carlo simulations suggest
that both quantitative and semi-quantitative analysis
methods are adequate for the kinetic characterisation of
time-activity curves acquired ex vivo from perfused
hearts. NLSA was found to be more accurate than SA in
Table 3 Results from the NLSA and SA quantification for [18 F]-FDG ex vivo datasets
18 F-FDG datasets
Normoxia Hypoxia 1 Hypoxia 2
1 2 3 4 1 2 3 4 1 2 3 4
α0 NLSA (min−1) 0.037 0.070 0.023 0.025 0.084 0.160 0.200 - 0.310 0.260 0.220 0.042
α0 SA (min−1) 0.038 0.005 0.037 - 0.064 - - - - 0.130 0.050 0.060
Patlak (min−1) 0.066 0.080 0.066 0.040 0.100 0.150 0.250 0.046 0.200 0.180 0.300 0.077
NA (a.u.) 0.015 0.025 0.025 0.015 0.023 0.050 0.020 0.020 0.040 0.040 0.072 0.021
α0 indicates the tracer trapping. Numbers 1, 2, 3, and 4 indicate the run number.
Figure 7 Results from the NLSA and SA analysis of experimental datasets. Mean ± SD of the trapping estimated with the NLSA (blue) and
SA (green) algorithm in normoxia and hypoxia for (A) [18 F]-FDG and (B) [18 F]-FMISO experimental datasets. ξ indicates n= 1 and *p< 0.05. α0 indicates
the trapping of the tracer.
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estimating the absence of trapping (α0 = 0 min
−1) for the
SNRs considered and for both tri- and bi-exponential kin-
etics. NLSA was also superior to SA in quantifying the
trapping component at low values of α0, while for higher
values of trapping, the performance of the two algorithms
was comparable.
The difference in performance of NLSA and SA in
the identification and quantification of the trapping
component is due to the different implementation of
the two algorithms. In SA, the possible values of the ex-
ponents βj (Equation 1) that best describe the experi-
mental data are chosen from a fixed grid of values and
only the values of αj are estimated. The optimal number
of exponents is therefore not chosen a priori and is
given by the number of rates βj for which a non-null αj
is estimated. The presence of noise can significantly re-
duce the accuracy of SA in identifying and quantifying
very low frequency (e.g. trapping) and high frequency
components [15] as well as introducing phantom kin-
etic components [12,16]. For the NLSA algorithm, the
experimental data are fitted with exponential curves of
increasing order, and both βj and αj are derived using a
non-linear least square estimator. In this case, all the
kinetic components, specified a priori, are estimated,
and the model that best fits the experimental data is
chosen a posteriori using a standard model parsimony
criterion [13]. This means that the very low frequency
and high frequency components are always estimated
and that the presence of noise can only affect the quan-
tification of the value of the components, but not their
identification.
SA was more accurate than NLSA in quantifying the
number of components different from α0, regardless the
value of the trapping and SNR for tri-exponential curves.
To determine whether estimating the correct number
of kinetic components using the NLSA algorithm was
dependent upon on the standard model parsimony criter-
ion used, we also implemented the SA algorithm where
the optimal model was chosen using the Bayesian infor-
mation criterion (BIC) rather than AIC. The AIC or BIC
for a model is usually written in the form [−2logL + kP],
where L is the likelihood function, P is the number of un-
known parameters in the model and k is 2 for AIC and
log(n) for BIC, with n number of points in the dataset.
BIC therefore penalises a model characterised by a larger
number of unknown parameters more than AIC does.
However, using BIC as parsimony criterion rather than
AIC, did not substantially improve the accuracy of the
NLSA algorithm in estimating the number of kinetic
components different from trapping.
Figure 8 Calculated values of Patlak and NA for experimental datasets. Mean ± SD of Patlak (orange) and NA (red) in normoxia and hypoxia
for (A) [18 F]-FDG and (B) [18 F]-FMISO experimental time-activity curve acquired ex vivo from perfused rat hearts. *p < 0.05.
Table 4 Results from the NLSA and SA quantification for [18 F]-FMISO ex vivo datasets
18 F-FMISO datasets
Normoxia Hypoxia 1 Hypoxia 2
1 2 3 1 2 3 1 2 3
α0 NLSA (min
−1) 0.004 0.008 0.004 0.033 0.025 0.011 0.050 0.040 0.023
α0 SA (min
−1) 0.004 - 0.005 0.010 0.016 0.002 0.020 0.015 0.013
Patlak (min−1) 0.005 0.007 0.004 0.015 0.018 0.054 0.450 0.025 0.024
NA (a.u.) 0.004 0.007 0.010 0.020 0.020 0.004 0.028 0.028 0.017
α0 indicates the tracer trapping. Numbers 1, 2, 3, and 4 indicate the run number.
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The accuracy of both algorithms in determining the
correct number of exponentials was significantly better
for bi-exponential dynamics, with accuracy close to 100%
for all cases studied. Two or more kinetic components
with close values are likely to be seen by SA and NLSA as
a unique component. The greater the spread of kinetic
values, the easier it is for the algorithms to discern the ex-
ponentials as separate components. In our simulations,
the values of the kinetic components βj were more spaced
in the bi-exponential than tri-exponential curves, meaning
that it was easier for SA and NLSA to discern the two
components as distinct βs.
The values estimated for Patlak and NA were found to
be linearly proportional to the simulated values of trap-
ping, but like spectral analysis, their estimation was af-
fected by the presence of the noise. The bias (percent)
associated with the estimation of Patlak was always higher
than that reported for the semi-quantitative index NA, for
all SNRs and trapping considered. Patlak is derived by cal-
culating the ratio between tissue retention of the tracer
and the delivery input function which decays rapidly to
zero. Both curves exhibit noise, and therefore, dividing two
noisy quantities amplifies the noise and reduces the accur-
acy of the method. The mean of the bias (percent) reported
for NA becomes smaller with increasing values of trapping
and SNRs, but the standard deviation does not change. In
our Monte Carlo simulations for a given SNR, we added
the same amount of noise to the time-activity curves with
different values of the trapping component. The standard
deviation of the bias is dependent on the noise variance of
the time-activity curve fitted, and therefore, it does not
change with increasing values of trapping for a given SNR.
For experimental datasets, the values reported for
CVα0 (%) suggest that NLSA is more accurate than SA for
the kinetic characterisation on ex vivo time-activity curves.
NLSA identified a trapping component for the [18 F]-FDG
datasets 11 times out of 12 and consistently indicated the
presence of trapping for the [18 F]-FMISO datasets. Add-
itionally, the trapping component quantified using NLSA
significantly increases with the level of hypoxia for both
[18 F]-FDG and [18 F]-FMISO, in agreement with previ-
ous studies [23]. In contrast, the Patlak values estimated
from the experimental time-activity curves of [18 F]-FDG
and [18 F]-FMISO (see Figure 8) are characterised by a
large variability due to the noise exhibited by both tissue
and input curves. An additional source of variability is as-
sociated with the nature of the ex vivo experiment where
there is no recirculation. Bolus injection of radiotracer
leads to a plasma activity that decays rapidly to zero, lead-
ing to an input function Cin(t) mainly characterised by low
SNR at later times.
Ex vivo time-activity curves have to be corrected for
the contribution of radioactivity from previous injections
to the residual tissue background signal in successive
injections. For both spectral-based algorithms, we cor-
rected for this residual activity by fitting the previous
injection and then subtracting the contribution of the
first injection to the second, and the contribution of the
first and second to the third. This approach assumes that
(1) the tracer studied is irreversibly trapped or, if revers-
ible, has decayed entirely before the subsequent injection;
(2) the concentration of exchangeable (reversible) tracer
in the tissue is negligible before the next injection; and
(3) the trapped component in a previous injection re-
mains trapped when the condition of the heart is chan-
ged. With the tracers (irreversible) used in this study and
the timing of their injections relative to their washout
kinetics, the tracer activity in the heart contributing to
each subsequent time-activity curve was very small and
was mainly represented by trapped tracer with the activ-
ity of the tracer in the equilibrating compartments almost
zero (<3% of the total measured signal). These conditions
are necessary to guarantee that the trapping rates quanti-
fied after the first injection are associated with changes in
tissue metabolism rather than the presence of residual
activity in the tissue.
Monte Carlo simulations showed that both NLSA and
SA are not able to reliably estimate the number of non-
trapping components characterising the tracer kinetics
especially when the number of rates is high. As a result,
the kinetic analysis of time-activity acquired ex vivo from
perfused hearts gives reliable information regarding the
trapping component of the tracer studied, but no informa-
tion of its transport/diffusion through the capillary mem-
brane or of its transport from the intracellular space into
the cells can be gained.
The Langendorff perfused heart has been the model of
choice of cardiologist for years and has greatly increased
our understanding of cardiac physiology. Nevertheless,
this experimental model has a number of limitations. Ex
vivo tissue time-activity curves are, for example, a het-
erogeneous measure of the tracer kinetics in the whole
heart, as opposed to data acquired from a more spatially
homogeneous voxel in imaging studies. It is expected
that the number of kinetic components returned by SA
approaches is higher than found within a given region
of tissue [13] due to heterogeneity of tracer kinetics.
While in vivo the coronary flow through the rat heart is
3 ml/min, in the buffer-perfused Langendorff heart, this
increases to approximately 14 ml/min at the same perfu-
sion pressure, due to the lower oxygen-carrying capacity
of Krebs buffer. Because the flow rate defines tracer deliv-
ery to the tissue, this might complicate interpretation of
semi-quantitative results where the bolus input is not
accounted for. However, semi-quantitative approaches
are simple to apply, and whilst less informative and more
sensitive to experimental conditions, the use of NA offers
a useful surrogate descriptor of tracer retention when
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datasets are acquired under an identical experimental
set-up and protocol.
When investigating the pharmacokinetics of metabolic
tracers like [18 F]-FDG, buffer substrate composition is
also a critical consideration. In the present study, hearts
were perfused with glucose as a sole energy substrate. The
lack of fatty acids in the perfusion medium and their influ-
ence on glucose transport and or downstream glycolysis
mean that [18 F]-FDG uptake may be different than that
seen in vivo. More elaborate perfusion media and the use
of membrane oxygenators would be required to study [18
F]-FDG metabolism under more physiologically appropri-
ate conditions.
Conclusions
Accurate quantification of radiotracer kinetics in the
Langendorff perfused heart is highly desirable for the char-
acterisation and development of novel radiotracers, and
the exploitation of existing tracers to probe biological pro-
cesses in greater detail. In this work, we compared the per-
formance of three quantitative (SA, NLSA and Patlak) and
one semi-quantitative (NA) analysis methods for the kin-
etic characterisation of ex vivo perfused heart time-activity
curves. We tested the SA and NLSA algorithms in terms
of the accuracy in identifying and quantifying the trapping
component and in estimating the kinetics of non-trapping
components. Results from both Monte Carlo simulations
and experimental data suggest that NLSA is the algorithm
of choice when the aim of the kinetic analysis is to assess
whether the radiotracer injected in the perfused heart is
irreversibly trapped or not. Once the presence of a fully
trapped component has been identified, it can be quanti-
fied using either NLSA or the semi-quantitative index NA.
Neither analysis methods were adequate for estimating the
number of non-trapping components characterising the
kinetics of ex vivo time-activity curves probably due to
the heterogeneity of the experimental preparation.
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